Smith & Nephew Publishes Q3 2026 Trading Update Transcript
- Smith & Nephew cut its 2026 underlying revenue growth forecast to approximately 3%, reflecting weak US knees and hips performance.
- At the November 4 third-quarter trading update, CEO Deepak Nath and interim CFO Pierre Palassian reported 3.4% underlying revenue growth.
- Full-year trading profit is now forecast at around USD 1.25 billion, with free cash flow of approximately USD 750 million.
- Discussions with J&J over a DePuy Synthes combination have ended; management continues actively exploring the full range of strategic options for Orthopaedics.
- LANDMARK's cemented knee version is expected in the second quarter of 2027, with meaningful commercial traction anticipated in the second half.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Smith & Nephew plc published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein.